Return to Article Details
CRISPR-CAS THERAPEUTICS AGAINST EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS: OPPORTUNITIES FOR PRECISION ANTIMICROBIAL INTERVENTION
Download
Download PDF